| Title |
Author |
Type |
Date |
Words |
| A Comparative Study on Efficacyof Lutein and Atorvastatin on Lipid Profile & Lipoprotein(a) in Hypercholesterolemic Male Wistar Rats. |
Priyadharsini, K. Soundarya; Ramanna, Mali Kalpana; Somu, L.; Prasad, T. Krishna |
Report |
Mar 1, 2021 |
4027 |
| Anti-Obesity Properties of Calocybe Indica In Zebrafishes with Short-term High-fat Diet Induction. |
Nagaraj, Anushree; Wilson, Sarah Andrea; Vaidyanathan, Lalitha |
Report |
Mar 1, 2021 |
5586 |
| A case of statin-associated immune-mediated necrotizing myopathy with atypical biopsy features. |
Zaki, Mark M.; Virk, Zain M.; Lopez, Diego; Klubnick, Jenna; Ahrendsen, Jared T.; Varma, Hemant; Kyt |
Clinical report |
Jan 1, 2021 |
3317 |
| COMPARISON OF LIPID LOWERING EFFECTS OF ROSUVASTATIN AND ATORVASTATIN IN TYPE 2 DIABETIC PATIENTS WITH PRIMARY HYPERLIPIDEMIA. |
Safina Shabbir, Zill-e-Humayun, Muhammad Adnan Manzar, Muhammad Javad Yousaf, Shabana Mushtaq and Ma |
|
Dec 31, 2020 |
2652 |
| DETERMINATION OF PHARMACOKINETIC PROFILE OF HIGH ORAL DOSE OFAN INNOVATOR BRAND OF ATORVASTATIN IN HEALTHY PAKISTANI VOLUNTEERS. |
Imrana Maqsood, Zarafshan Bader, Ayesha Janjua, Shezadi Sabah Imran, Aroosa Ishtiaq Butt and Mehwish |
|
Aug 31, 2020 |
2934 |
| Sea Buckthorn and Grape Antioxidant Effects in Hyperlipidemic Rats: Relationship with the Atorvastatin Therapy. |
Mohamed, Erieg A.; Bordean, Despina M.; Radulov, Isidora; Moruzi, Razvan F.; Hulea, Calin I.; Orasan |
|
Jul 31, 2020 |
4857 |
| Co-prescription of ciprofloxacin and statins; a dangerous combination: Case report. |
Irfan, Farhana; Karim, Syed Irfan |
Clinical report |
Jul 10, 2020 |
1533 |
| Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via p38 Signaling. |
Li, Tangzhiming; Li, Suqi; Feng, Yilu; Zeng, Xiaofang; Dong, Shaohong; Li, Jianghua; Zha, Lihuang; L |
|
Jun 30, 2020 |
6977 |
| THE EFFECT OF ATORVASTATIN ON THE COMMON CAROTID ARTERY INTIMA-MEDIA THICKNESS IN PATIENTS WITH ISCHEMIC STROKE/UCINAK ATORVASTATINA NA DEBLJINU ARTERIJSKE INTIME MEDIJE U BOLESNIKA S ISHEMIJSKIM MOADANIM UDAROM. |
Khazaei, Mojtaba; Khosravi, Mozhdeh; Mazaheri, Shahir; Mazdeh, Mehrdokht; Ghiasian, Masoud; Taheri, |
Report |
Jun 1, 2020 |
2143 |
| Comparing the Effect of Combining Exercise with Rosuvastatin versus Atorvastatin on Lipid Profile and Functional Capacity: A Retrospective Cohort Study. |
Eltonsy, Sherif; Doiron, Monique Dufour; Simard, Patrice; Jose, Caroline; Senechal, Martin; Bouchard |
|
May 31, 2020 |
8030 |
| Cholangiolytic Changes in Statin-Induced Liver Injury. |
Menon, Preethi Dileep; Singh, Tamneet; Hubbard, Hopethe; Hackman, Sarah; Sharkey, Francis E. |
|
Mar 1, 2020 |
2508 |
| Evaluation of Orally Administered Atorvastatin on Plasma Lipid and Biochemistry Profiles in Hypercholesterolemic Hispaniolan Amazon Parrots (Amazona venir alis). |
Robertson, Jessica A.; Guzman, David Sanchez-Migallon; Graham, James L.; Stanhope, Kimber L.; Dougla |
Report |
Mar 1, 2020 |
5979 |
| Atorvastatin Improves Hepatic Lipid Metabolism and Protects Renal Damage in Adenine-Induced Chronic Kidney Disease in Sprague-Dawley Rats. |
Ghelani, Hardik; Razmovski-Naumovski, Valentina; Inampudi, Vamsi; Chang, Dennis; Namm, Srinivas |
|
Nov 30, 2019 |
7310 |
| Atorvastatin API Market 2019 Global Size, Industry Growth, Profit Analysis, Segments and Recent Trends by Forecast to 2023. |
|
|
Nov 7, 2019 |
931 |
| Polyethylene Glycol-Coated Gold Nanoparticles as DNA and Atorvastatin Delivery Systems and Cytotoxicity Evaluation. |
Zamora-Justo, Jose Alberto; Abrica-Gonzalez, Paulina; Vazquez-Martinez, Guillermo Rocael; Munoz-Dios |
|
Oct 31, 2019 |
5939 |
| Duloxetine Intermediates and Atorvastatin Intermediates Market Size and Share 2019 / Future Trends, Growth Analysis, Application and Global Industry Insights By 2023. |
|
|
Oct 28, 2019 |
784 |
| The Effects of Administration of Vitamin D, Infliximab, and Leflunomide on Testosterone Concentrations in Rats under Atorvastatin Therapy. |
Aykan, Duygun Altintas; Seyithanoglu, Muhammed |
|
Oct 1, 2019 |
3619 |
| Atorvastatin API Market to Cross USD 4,25,804.16 thousand by 2023, Global Industry Size, Growth, Share, SWOT Analysis, Competitive Landscape, Key Players, Regional Forecast to 2023. |
|
|
Sep 12, 2019 |
968 |
| EFFICACY OF ATORVASTATIN IN REDUCING PROTEINURIA IN PATIENTS OF CHRONIC KIDNEY DISEASE. |
|
|
Aug 31, 2019 |
2478 |
| Atorvastatin and Conditioned Media from Atorvastatin-Treated Human Hematopoietic Stem/Progenitor-Derived Cells Show Proangiogenic Activity In Vitro but Not In Vivo. |
Nowak, Witold N.; Taha, Hevidar; Markiewicz, Joanna; Kachamakova-Trojanowska, Neli; Stepniewski, Jac |
|
Jul 31, 2019 |
7590 |
| The Effects of Atorvastatin on the Migraine Pathophysiology in Nitroglycerin Induced Migraine in Ovariectomized Rats. |
Hicyilmaz, Ahmet Can; Akgun-Dar, Kadriye |
|
Jun 1, 2019 |
8340 |
| Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB). |
Ma, Qing; Gao, Yang; Xu, Pei; Li, Kai; Xu, Xiaolong; Gao, Jingbo; Qi, Yuwen; Xu, Jingjing; Yang, Yan |
|
Apr 30, 2019 |
7092 |
| Development of a Discriminative and Biorelevant Dissolution Test Method for Atorvastatin/Fenofibrate Combination with Appliance of Derivative Spectrophotometry/Turev Spektrofotometrik Yontem ile Atorvastatin/Fenofibrat Kombinasyonunda Ayirici ve Biyouyumlu Cozunme Testi Metodunun Gelistirilmesi. |
Anumolu, Panukumar Durga; Gurrala, Sunitha; Satya, Subrahmanyam Chavali Venkata; Polisetty, Santoshi |
Report |
Mar 1, 2019 |
3665 |
| TO EVALUATE THE EFFECTS OF PITAVASTATIN ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH HYPERCHOLESTEROLEMIA WHO WERE PREVIOUSLY BEING TREATED WITH ATORVASTATIN. |
|
|
Feb 28, 2019 |
3404 |
| A case of xanthoma disseminatum: A rare type of non-Langerhans cell histiocytosis. |
|
|
Sep 30, 2018 |
1790 |
| EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA. |
Naydenov, Stefan Naydenov; Runev, Nikolay Margaritov; Manov, Emil Ivanovc; Torbova-Gigova, Svetla Ge |
Report |
Sep 1, 2018 |
4823 |
| Twin USFDA approvals for Morepen Labs' bulk drugs (API) facilities. |
|
|
Jul 30, 2018 |
691 |
| Evaluation of the Cytotoxic and Autophagic Effects of Atorvastatin on MCF-7 Breast Cancer Cells. |
Martinez, Tugba Alarcon; Zeybek, Naciye Dilara; Muftuoglu, Sevda |
Report |
Jun 1, 2018 |
3796 |
| A Case of Atorvastatin-Associated Necrotizing Autoimmune Myopathy, Mimicking Idiopathic Polymyositis. |
Dixit, Ayushi; Abrudescu, Adriana |
|
Jan 1, 2018 |
1905 |
| Is Atorvastatin Associated with New Onset Diabetes or Deterioration of Glycemic Control? Systematic Review Using Data from 1.9 Million Patients. |
Angelidi, Angeliki M.; Stambolliu, Emelina; Adamopoulou, Konstantina I.; Kousoulis, Antonis A. |
|
Jan 1, 2018 |
11160 |
| Atorvastatin Downregulates In Vitro Methyl Methanesulfonate and Cyclophosphamide Alkylation-Mediated Cellular and DNA Injuries. |
Araujo-Lima, Carlos F.; Christoni, Larissa S.A.; Justo, Graca; Soeiro, Maria N.C.; Aiub, Claudia A.F |
|
Jan 1, 2018 |
7441 |
| Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis. |
|
Report |
Dec 31, 2017 |
3022 |
| Statins: Are they also memory enhancers? A study in relation to their hypocholesterolemic and antioxidant effects in Swiss albino mice. |
Mishra, Manas Ranjan; Nayak, Prakash Kumar; Sarangi, Rajlaxmi |
Report |
Dec 1, 2017 |
4030 |
| Comparative evaluation of atorvastatin and simvastatin on critical fusion frequency in healthy volunteers. |
Khajuria, Vijay; Rani, Neelam; Sadiq, Shamiya; Tandon, Vishal; Gupta, Roshi |
Report |
Dec 1, 2017 |
2374 |
| Simultaneous Voltammetric Determination of Amlodipine and Atorvastatin on Anodically Pretreated Boron-Doped Diamond Electrode. |
Rebech, Igor; Salamanca-Neto, Carlos Alberto Rossi; Scremin, Jessica; Sartori, Elen Romao |
Report |
Jul 1, 2017 |
5284 |
| Atorvastatin-Medicated Dentifrice Significantly Inhibits CD4+ T Cell Proliferation: In vitro Pilot Study/ Pasta Dental Medicada con Atorvastatina Inhibe de Forma Significativa la Proliferacion de Celulas T CD4+: Un Estudio Piloto In vitro. |
Rosenberg, David R.; Kernitsky, Jeremy R.; Andrade, Catherine X.; Ramirez, Valeria; Violant, Deborah |
|
Jun 1, 2017 |
4816 |
| Severe Rhabdomyolysis as Complication of Interaction between Atorvastatin and Fusidic Acid in a Patient in Lifelong Antibiotic Prophylaxis: A Dangerous Combination. |
Nandy, Anirban; Gaini, Shahin |
Case overview |
Jan 1, 2017 |
2452 |
| Atorvastatin-Diltiazem Combination Induced Rhabdomyolysis Leading to Diagnosis of Hypothyroidism. |
Ehelepola, N.D.B.; Sathkumara, S.M.B.Y.; Bandara, H.M.P.A.G.S.; Kalupahana, K.L.R. |
Case study |
Jan 1, 2017 |
2699 |
| Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor. |
Banakh, Iouri; Haji, Kavi; Kung, Ross; Gupta, Sachin; Tiruvoipati, Ravindranath |
Report |
Jan 1, 2017 |
2714 |
| Rhabdomyolysis Induced by Coadministration of Fusidic Acid and Atorvastatin: A Case Report and Comprehensive Review of the Literature. |
Patoulias, Dimitrios; Michailidis, Theodoros; Papatolios, Thomas; Papadopoulos, Rafael; Keryttopoulo |
Case study |
Jan 1, 2017 |
2185 |
| Comparison of Effects of Different Statins on Contrast-Induced Acute Kidney Injury in Rats: Histopathological and Biochemical Findings. |
Wang, Xiao-lei; Zhang, Tuo; Hu, Liu-hua; Sun, Shi-qun; Zhang, Wei-feng; Sun, Zhe; Shen, Ling-hong; H |
Report |
Jan 1, 2017 |
5027 |
| Effect of Prior Atorvastatin Treatment on the Frequency of Hospital Acquired Pneumonia and Evolution of Biomarkers in Patients with Acute Ischemic Stroke: A Multicenter Prospective Study. |
Yu, Yuetian; Zhu, Cheng; Liu, Chunyan; Gao, Yuan |
Report |
Jan 1, 2017 |
5344 |
| Is an SGLT2 inhibitor right for your patient with type 2 diabetes? |
Lisenby, Katelin M.; Meyer, Allison; Slater, Nicole A. |
Report |
Sep 1, 2016 |
4728 |
| Effect of systemic administration of HMG Co a reductase inhibitor atorvastatin on central retinal artery flow dynamics, intra ocular pressure and visual field changes in primary open angle glaucoma and normal tension glaucoma patients. |
Sharma, Deepak Kumar; Chaudhary, K.P.; Negi, P.C.; Tuli, Rajeev |
Clinical report |
Dec 3, 2015 |
5858 |
| Resources for ad caregivers....therapy to help insomnia....memory problems and statins. |
|
Column |
Dec 1, 2015 |
542 |
| Ezetimibe with atorvastatin boosts plaque regression. |
Moon, Mary Ann |
Report |
Sep 1, 2015 |
348 |
| The effect of physical activity and Atorvastatin action on lipid profile of sedentary and non sedentary alcoholic myocardial infarction patients. |
Syamala, D.; Kumari, N. Indira; Pavan, G. Teja |
|
Feb 5, 2015 |
1630 |
| High levels of LDL-C combined with low levels of HDL-C further increase platelet activation in hypercholesterolemic patients. |
Chan, L.W.; Luo, X.P.; Ni, H.C.; Shi, H.M.; Liu, L.; Wen, Z.C.; Gu, X.Y.; Qiao, J.; Li, J. |
Report |
Feb 1, 2015 |
4701 |
| Use of Atorvastatin in Lipid Disorders and Cardiovascular Disease in Chinese Patients. |
Ye, Yi-Cong; Zhao, Xi-Liang; Zhang, Shu-Yang |
Report |
Feb 1, 2015 |
6321 |
| Evaluation of muscle performance with isokinetic test in patients using atorvastatin/Atorvastatin kullanan hastalarda kas performansinin izokinetik test ile degerlendirilmesi. |
Ozturk, Gokhan Tuna; Topal, Salih; Ozdemir, Murat; Gogus, Feride |
Report |
Mar 1, 2014 |
2614 |
| Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion. |
Zhao, X.J.; Liu, X.L.; He, G.X.; Xu, H.P. |
Report |
Mar 1, 2014 |
4227 |
| Atorvastatin represses the angiotensin 2-induced oxidative stress and inflammatory response in dendritic cells via the PI3K/Akt/Nrf 2 pathway. |
Ma, Yuanji; Chen, Zhaoyang; Zou, Yunzeng; Ge, Junbo |
Report |
Jan 1, 2014 |
4842 |
| Atorvastatin treatment does not alter pulse wave velocity in healthy adults. |
Ballard, Kevin D.; Taylor, Beth A.; Capizzi, Jeffrey A.; Grimaldi, Adam S.; White, C. Michael; Thomp |
Report |
Jan 1, 2014 |
3753 |
| Stability indicating RP-HPLC method for the simultaneous determination of atorvastatin calcium, metformin hydrochloride, and glimepiride in bulk and combined tablet dosage form. |
Ramesh, Devi; Habibuddin, Mohammad |
Report |
Jan 1, 2014 |
4190 |
| Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention. |
|
|
Jun 30, 2013 |
3034 |
| Study of effects of a combination of Biochanin A and Atorvastatin on signal transduction and invasiveness of pancreatic cancer cell lines. |
Tadinada, Satya Murthy; Bhushan, Alok; Lai, James C.K. |
Abstract |
Jun 1, 2013 |
227 |
| What matters: atorvastatin for erectile dysfunction. |
Ebbert, Jon O. |
Clinical report |
Apr 1, 2013 |
419 |
| No wider recall for glass-tainted generic Lipitor. |
|
|
Mar 11, 2013 |
263 |
| Comparison of rosuvastatin and atorvastatin in achieving the treatment goals of dyslipidemia. |
Jyoti, Naresh; Poonam; Rai, Jaswant; Kaur, Sharanjit; Dhillon, Ashok |
Clinical report |
Feb 11, 2013 |
3786 |
| Merck receives FDA acknowledgement of resubmission of NSA for Ezetimibe/Atorvastatin tablets. |
|
|
Jan 3, 2013 |
142 |
| Merck receives FDA acknowledgement of resubmission of NSA for Ezetimibe/Atorvastatin tablets. |
|
|
Jan 3, 2013 |
138 |
| Resolution of ternary mixture of aspirin, atorvastatin, and clopidogrel by chemometric-assisted UV spectroscopic and liquid chromatography methods. |
Issa, Mahmoud Mohamed; Nejem, R'afat Mahmoud; Shanab, Alaa Abu; Staden, Raluca- Ioana Stefan-van |
Report |
Jan 1, 2013 |
4814 |
| EVALUATION OF EFFICACY OF ATORVASTATIN IN PREVENTION OF CARDIOVASCULAR RISKS IN STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS. |
|
|
Dec 31, 2012 |
3795 |
| Atorvastatin recalled for ground glass contamination. |
Splete, Heidi |
|
Dec 1, 2012 |
288 |
| Ranbaxy Recalls Generic Lipitor In US For Possible Presence Of Glass Particle. |
|
|
Nov 23, 2012 |
378 |
| Meijer adds free generic to offerings. |
|
|
Sep 24, 2012 |
206 |
| Dr. Reddya[euro](tm)s Laboratories Ltd unveils Atorvastatin Calcium tablets in the US market. |
|
|
Jul 19, 2012 |
169 |
| Generic Anti-Cholesterol Drug Introduced by Dr Reddya[euro](tm)s in US. |
|
|
Jul 19, 2012 |
130 |
| Generic Anti-Cholesterol Drug Introduced by Dr Reddya[euro](tm)s in US. |
|
|
Jul 19, 2012 |
126 |
| Synergistic inhibition of interleukin-6 production in adipose stem cells by tart cherry anthocyanins and atorvastatin. |
Zhou, Zhou; Nair, Muraleedharan G.; Claycombe, Kate J. |
Report |
Jul 15, 2012 |
2209 |
| Mylan Inc awarded tentative FDA approval for generic cardiovascular drug Lipitor. |
|
|
Feb 3, 2012 |
139 |
| Atorvastatin rivals rosuvastatin at max dosage. |
Zoler, Mitchel L. |
|
Jan 1, 2012 |
1128 |
| Generic atorvastatin 'game changer'. |
Lloyd-Jones, Donald M. |
Brief article |
Jan 1, 2012 |
274 |
| Mylan Inc unveils generic Caduet tablets for hypertension treatment. |
|
|
Dec 2, 2011 |
181 |
| Teva Pharmaceutical Industries Ltd awarded tentative US FDA approval for Atorvastatin Calcium Tablets. |
|
|
Dec 2, 2011 |
151 |
| Teva gains FDA tentative approval of generic Lipitor. |
|
|
Dec 2, 2011 |
149 |
| Atorvastatin rivals rosuvastatin at max dosage. |
Zoler, Mitchel L. |
|
Dec 1, 2011 |
1250 |
| Teva signs deal with Ranbaxy for generic version of Lipitor. |
|
|
Dec 1, 2011 |
134 |
| Teva signs agreement with Ranbaxy for generic Lipitor. |
|
|
Dec 1, 2011 |
129 |
| Statins for patients with nonalcoholic fatty liver? Although physicians often avoid prescribing statins for patients with nonalcoholic fatty liver, their use has been found to reduce cardiovascular morbidity and mortality - and to lower liver enzymes. |
Egan, Mari; Prasad, Shailendra |
|
Sep 1, 2011 |
1584 |
| FDA sued over generic lipitor. |
Anderson, Jane |
|
Apr 15, 2011 |
162 |
| Antinecroinflammatory effects of atorvastatin against carbon tetra chloride-induced hepatotoxicity in rats. |
Doustar, Y.; Mohajeri, D.; Mousavi, Gh.; Rezaii, A.; Safarmashaei, S. |
Report |
Apr 1, 2011 |
2703 |
| Combined use of ginger and atorvastatin. |
Finney-Brown, Tessa |
|
Mar 22, 2011 |
804 |
| Effect of combined administration of ginger (Zingiber officinale Roscoe) and atorvastatin on the liver of rats. |
Heeba, Gehan H.; Abd-Elghany, Manal I. |
Report |
Dec 1, 2010 |
4462 |
| Watson Pharmaceuticals launches Atorvastatin Calcium Tablets in Canada. |
|
|
May 20, 2010 |
153 |
| Atorvastatin induced multiple organ failure. |
Kandavar, Ramprasad; Sander, Gary E. |
Case study |
May 1, 2010 |
1146 |
| Effect of total saponins of "panax notoginseng root" on aortic intimal hyperplasia and the expressions of cell cycle protein and extracellular matrix in rats. |
Wu, Lu; Zhang, Wei; Tang, Ying-Hong; Li, Hua; Chen, Bei-Yang; Zhang, Guo-Min; Deng, Chang-Qing |
Clinical report |
Mar 1, 2010 |
5863 |
| Mylan gets sued by Pfizer for generic Caduet. |
|
|
Feb 10, 2010 |
236 |
| Q/What does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL? |
Nelson, Carrie; Hitchcock, Kristin; Bohlen, James A. |
|
Dec 1, 2009 |
1341 |
| Merck & Co. |
|
Brief article |
Nov 9, 2009 |
144 |
| Lipitor-associated memory loss: analysis of 662 cases of cognitive damage. |
Graveline, Duane; Cohen, Jay S. |
Report |
Jun 1, 2009 |
4973 |
| The results of a study using a special MRI technique suggest that treatment with high-dose atorvastatin can reduce inflammation in carotid artery plaques, which may help prevent rupture and, therefore, stroke. |
|
Brief article |
May 11, 2009 |
264 |
| Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients. |
|
Brief article |
May 1, 2009 |
199 |
| Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification. |
|
Report |
May 1, 2009 |
427 |
| Impact of atorvastatin plus n-3 PUFA on metabolic, inflammatory and coagulative parameters in metabolic syndrome without and with type 2 diabetes mellitus. |
Avellone, Gino; Guarnotta, Valentina; Di Garbo, Vincenzo; Abruzzese, Giovanni; Campisi, Domenico; Pi |
Report |
Jan 1, 2009 |
9975 |
| How to reach LDL targets quickly in patients with diabetes or metabolic syndrome: with a simple algorithm developed from the ACTFAST trials, most patients can reach goal safely in 6 to 12 weeks. |
Leiter, Lawrence A.; Martineau, Pierre; de Teresa, Eduardo; Farsang, Csaba; Gaw, Allan; Gensini, Gia |
Clinical report |
Oct 1, 2008 |
4704 |
| Fewer CV events may occur with atorvastatin. |
Finn, Robert |
|
Sep 1, 2008 |
575 |
| A combination of a low dose of atorvastatin (Lipitor) and a low dose of celecoxib (Celebrex) potently inhibits the androgen-independent growth of prostate cancer in an animal model, according to research reported at the American Association of Cancer Research 2008 annual meeting in San Diego. |
|
Brief article |
Apr 21, 2008 |
151 |
| Lipid-lowering may improve cognition in A-Fib. |
Jancin, Bruce |
|
Nov 15, 2007 |
579 |
| Pre-PCI atorvastatin reduces cardiac events. |
Bates, Betsy |
|
May 15, 2007 |
485 |
| Lipitor, HepaGam B. |
Mechcatie, Elizabeth |
|
May 1, 2007 |
843 |
| CVD duet offers benefits. |
|
|
May 1, 2007 |
241 |
| CVD duet offers benefits. |
|
Brief article |
May 1, 2007 |
241 |
| Lipitor gets five more indications. |
|
Brief article |
Apr 23, 2007 |
185 |
| Pfizer's Lipitor reduces chance of additional strokes. |
|
Drug overview |
Jan 1, 2007 |
416 |
| Atorvastatin cuts stroke risk. |
|
Brief article |
Nov 1, 2006 |
296 |
| Atorvastatin stems stroke recurrence. |
|
Brief article |
Oct 1, 2006 |
225 |
| Statin drug may reduce risk of recurrent stroke. |
|
Brief article |
Oct 1, 2006 |
182 |
| Rosuvastatin better than atorvastatin in blacks. |
Finn, Robert |
Brief article |
Sep 15, 2006 |
270 |
| Statin pretreatment cuts risk of postop atrial fib. |
Evans, Rita |
Clinical report |
Aug 15, 2006 |
435 |
| High-dose statin aids renal function in CHD. |
Jancin, Bruce |
Disease/Disorder overview |
Jun 15, 2006 |
667 |
| Statins improve renal function in heart patients. |
Jancin, Bruce |
|
May 1, 2006 |
657 |
| Intensive atorvastatin cuts hospitalization in heart failure, secondary analysis shows. |
Zoler, Mitchel L. |
|
Mar 1, 2006 |
572 |
| Data point to amlodipine, atorvastatin synergy: evidence obtained from ASCOT may lead to more aggressive use of statins in hypertensive patients. |
Zoler, Mitchel L. |
|
Dec 15, 2005 |
798 |
| Counterfeit Lipitor batch is recalled. |
Moon, Mary Ann |
Brief Article |
Sep 1, 2005 |
159 |
| Diabetic CHD patients need lipid lowering, too. |
Tucker, Miriam E. |
|
Jul 15, 2005 |
875 |
| CV risk persists in atorvastatin Tx of type 2 diabetics on dialysis. |
Ingram, Jerry |
|
Apr 15, 2005 |
407 |
| High-dose atorvastatin linked to hyperglycemia. |
Zoler, Mitchel L. |
|
Apr 15, 2005 |
609 |
| High-dose atorvastatin may slow the progression of Alzheimer's disease. |
Jancin, Bruce |
|
Feb 1, 2005 |
549 |
| CV risk despite atorvastatin in type 2 diabetics on dialysis. |
Ingram, Jerry |
|
Jan 1, 2005 |
410 |
| Atorvastatin delays first MI for patients with diabetes. |
|
|
Dec 1, 2004 |
314 |
| Statin averts CVD events in type 2 diabetic patients: CARDS data show 37% decline in major events, regardless of baseline LDL level. |
Tucker, Miriam E. |
|
Jul 1, 2004 |
1297 |
| Combo therapy for hypertension, dyslipidemia. |
Jancin, Bruce |
|
Jun 1, 2004 |
356 |
| One pill works for concomitant HT, Dyslipidemia: Caduet boosts treatment success rates. |
|
Brief Article |
May 15, 2004 |
308 |
| The prove IT-TIMI 22 trial: drive LDL down to 60 mg/dL after coronary event; High-dose statin regimen yielded a highly significant 16% relative reduction in risk. |
Jancin, Bruce |
|
Apr 1, 2004 |
922 |
| Atorvastatin lowers plasma matrix metalloproteinase-9 in patients with acute coronary syndrome. |
Zhumei, Xu; Shuiping, Zhao; Hongnian, Zhou; Huijun, Ye; Jiang, Li |
|
Apr 1, 2004 |
2413 |
| Caduet. |
Mechcatie, Elizabeth |
|
Mar 15, 2004 |
338 |
| Caduet. |
Mechcatie, Elizabeth |
|
Mar 15, 2004 |
342 |
| Intensive statin regimen may halt atherosclerosis: measured by intravascular ultrasound: 'maximally intensive ... therapy can completely halt the disease process.'. |
Zoler, Mitchel L. |
|
Dec 15, 2003 |
743 |
| Intensive statin regimen can stop atherosclerosis: atorvastatin tops pravastatin: some experts urge caution about posthoc analysis of LDL cholesterol reductions. |
Zoler, Mitchel L. |
|
Dec 1, 2003 |
759 |
| Ezetimibe plus atorvastatin lowers cholesterol. |
Madigosky, Wendy S.; Kane, Kevin Y. |
|
Sep 1, 2003 |
732 |
| Metabolic syndrome: control lipids aggressively: industry sponsored symposium. |
Tucker, Miriam E. |
|
Sep 1, 2003 |
582 |
| More time needed for adverse events reporting; drugs granted pediatric exclusivity. |
Sullivan, Michele G. |
|
Aug 1, 2003 |
573 |
| Atorvastatin nips events in normolipidemic HT. (Ascot Study Results). |
Jancin, Bruce |
|
May 1, 2003 |
486 |
| In normolipidemic HT, atorvastatin lowers CVD rate: relative risk of events drops 36% vs. placebo in well-controlled hypertension. (Atorvastatin 10 Mg/Day). |
Jancin, Bruce |
|
May 1, 2003 |
569 |
| Simvastatin bests atorvastatin at maximum doses. (Better Tolerated, Boosts HDL Higher). |
Jancin, Bruce |
|
Nov 1, 2002 |
378 |
